In conclusion, in a xenograft model of human melanoma in scid mice, we found that monotherapy with an antibody targeting YKL-40 rapidly enhances melanoma tumor size at least in part by increasing the formation of new tumor vessels. The gene discussed is CHI3L1; the disease is melanoma.